chamuvarinin: from the roots of Uvaria chamae; structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Uvaria | genus | A plant genus of the family ANNONACEAE. Members contain uvarigrin, uvarigrandin, chamuvaritin and other acetogenins and benzylisoquinoline alkaloids.[MeSH] | Annonaceae | The custard-apple plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. Some members provide large pulpy fruits and commercial timber. Leaves and wood are often fragrant. Leaves are simple, with smooth margins, and alternately arranged in two rows along the stems.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 11342455 |
CHEMBL ID | 457676 |
MeSH ID | M0470438 |
Synonym |
---|
CHEMBL457676 |
chamuvarinin |
Q15410884 |
(2s)-4-[(13r)-13-[(2r,5r)-5-[5-(6-hexyloxan-2-yl)oxolan-2-yl]oxolan-2-yl]-13-hydroxytridecyl]-2-methyl-2h-furan-5-one |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID402924 | Cytotoxicity against human KB3-1 cells by colorimetric assay | 2004 | Journal of natural products, Jun, Volume: 67, Issue:6 | Chamuvarinin, an acetogenin bearing a tetrahydropyran ring from the roots of Uvaria chamae. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.79) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |